MMWR Morb Mortal Wkly Rep. 1996 Nov 1;45(43):947-9.
Because of the rapidly emerging resistance of Streptococcus pneumoniae (SP) infections to penicillin and other antimicrobial agents, the Drug-Resistant Streptococcus pneumoniae Working Group (DRSPWG) was established in 1993 to develop a strategy to minimize the impact of drug-resistant SP (DRSP). Based on a recommendation from the DRSPWG, in 1994 the Council of State and Territorial Epidemiologists (CSTE) resolved that each state should designate as reportable to state and federal officials all invasive infections caused by DRSP. In 1995, health departments in 14 jurisdictions (Arkansas, Colorado, Connecticut, Georgia, Michigan, Minnesota, Missouri, New Hampshire, New Jersey, New York, North Carolina, Ohio, South Carolina, and New York City) instituted regulations requiring laboratories to report the isolation of DRSP from specimens obtained from normally sterile sites (e.g., cerebrospinal fluid and blood). To determine the impact of the CSTE resolution on nationwide reporting of DRSP, in May 1996 CDC conducted a telephone survey of public health officials in all states, New York City, and the District of Columbia. This report summarizes the survey findings, which indicate an increase in the proportion of jurisdictions that conduct surveillance for DRSP.
由于肺炎链球菌（SP）感染对青霉素和其他抗菌药物的耐药性迅速出现，耐药肺炎链球菌工作组（DRSPWG）于1993年成立，以制定一项战略，尽量减少耐药SP（DRSP）的影响。根据DRSPWG的一项建议，1994年州和地区流行病学家理事会（CSTE）决定，每个州都应将所有由DRSP引起的侵袭性感染指定为向州和联邦官员报告的疾病。1995年，14个司法管辖区（阿肯色州、科罗拉多州、康涅狄格州、佐治亚州、密歇根州、明尼苏达州、密苏里州、新罕布什尔州、新泽西州、纽约州、北卡罗来纳州、俄亥俄州、南卡罗来纳州和纽约市）的卫生部门制定了法规，要求实验室报告从通常无菌部位（如脑脊液和血液）获取的标本中分离出DRSP的情况。为了确定CSTE决议对全国范围内DRSP报告的影响，1996年5月，疾病控制与预防中心（CDC）对所有州、纽约市和哥伦比亚特区的公共卫生官员进行了电话调查。本报告总结了调查结果，结果表明对DRSP进行监测的司法管辖区比例有所增加。
